source
- FDA approves Nuvalent lung cancer drug shortly after GSK completes $10.6 billion acquisitionThe FDA announced Wednesday that it has approved a lung cancer medicine from Nuvalent, marking a key regulatory milestone for the biotech. The clearance arrived just a week after GlaxoSmithKline c…
- Trump threatens up to 200% tariffs on generic drugs not manufactured in the United StatesPresident Donald Trump announced that his administration will consider imposing steep tariffs on generic medicines that are imported rather than produced in the United States. The proposed tariffs…